(Q41067509)

26 September 2017

Effect of dual-subtype vaccine against feline immunodeficiency virus infection (English)

1 reference

feline immunodeficiency virus

26 September 2017

object named as

feline immunodeficiency virus

1 reference

Hohdatsu T

1

1 reference

26 September 2017

Okada S

2

1 reference

26 September 2017

Motokawa K

3

1 reference

26 September 2017

Aizawa C

4

1 reference

26 September 2017

Yamamoto JK

5

1 reference

26 September 2017

Koyama H

6

1 reference

26 September 2017

1 November 1997

1 reference

26 September 2017

11

1 reference

inferred from page(s)

published in

Veterinary Microbiology

1 reference

26 September 2017

58

1 reference

26 September 2017

2-4

1 reference

26 September 2017

155-165

1 reference

Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.

26 September 2017

1 reference

12 December 2020

Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus

1 reference

12 December 2020

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines

1 reference

12 December 2020

Vaccination against feline immunodeficiency virus using fixed infected cells

1 reference

12 December 2020

Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies

1 reference

12 December 2020

Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns

1 reference

12 December 2020

Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats

1 reference

12 December 2020

Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection

1 reference

12 December 2020

Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents

1 reference

12 December 2020

Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity

1 reference

12 December 2020

FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.

1 reference

12 December 2020

Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies

1 reference

12 December 2020

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

1 reference

12 December 2020

A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity

1 reference

12 December 2020

Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus.

1 reference

12 December 2020

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

1 reference

12 December 2020

Passive antibody protection of cats against feline immunodeficiency virus infection

1 reference

12 December 2020

Enhancement after feline immunodeficiency virus vaccination

1 reference

12 December 2020

Tenth anniversary perspectives on AIDS. FIV as a model for AIDS vaccination

1 reference

12 December 2020

Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes

1 reference

12 December 2020

Feline immunodeficiency virus infection

1 reference

12 December 2020

Development of IL-2 Independent Feline Lymphoid Cell Lines Chronically Infected with Feline Immunodeficiency Virus: Importance for Diagnostic Reagents and Vaccines

1 reference

12 December 2020

Experimental vaccine protection against feline immunodeficiency virus

1 reference

12 December 2020

The development of a vaccine against feline immunodeficiency virus

1 reference

12 December 2020

Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus

1 reference

12 December 2020

Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtypes A, B and D classified on the basis of the env gene V3-V5 sequence.

1 reference

12 December 2020

Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination

1 reference

12 December 2020

Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus

1 reference

12 December 2020

Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection

1 reference

12 December 2020

Genetic diversity of Argentine isolates of feline immunodeficiency virus

1 reference

12 December 2020

Detection of feline immunodeficiency proviral DNA in peripheral blood lymphocytes by the polymerase chain reaction

1 reference

12 December 2020

Anti-cell antibody in macaques

1 reference

12 December 2020

Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines

1 reference

12 December 2020

The prevalence of types I and II feline coronavirus infections in cats

1 reference

12 December 2020

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

1 reference

12 December 2020

FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.

1 reference

12 December 2020

Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections

1 reference

12 December 2020

Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

1 reference

12 December 2020

10.1016/S0378-1135(97)00164-8

Identifiers

DOI

1 reference

26 September 2017

1 reference